Polypeptide and protein derivatives and process for their preparation
AssigneeAmylin Pharmaceuticals, Inc.
InventorsRobin Ewart Offord, Keith Rose
Life of this patent
Estimating the term…
Abstract
Protein and polypeptid derivatives and th ir salts are claimed characteriz d in that a prot in or polypeptide is conjugated via an int rmediat grouping containing at least one radical of the formula —C(R)═N— (or —N═C(R)—) or —CH(R)—NH— (or —NH—CH(R)—), wherein R is hydrogen or a hydrocarbon residue which may be substituted, with the same or a different protein or polypeptide, with a reporter group or a cytotoxic agent as well as a process for their preparation and the novel intermediates therefor.
Claims46
A modified protein or polyp ptide or a salt ther of comprising a protein or polypeptide conjugated by an intermediate group containing at least one radical having the formula —C(R)═N—, —N═C(R)—, —CH(R)—NH— or —NH—CH(R)—, in which R is hydrogen or an aliphatic, cycloaliphatic, aromatic or araliphatic hydrocarbon group, which group may be substituted with the same or a different protein or polypeptide, a reporter group or a cytotoxic agent.
A modified protein or polypeptide having the formula
- A-X—R1′, (II′)
- in which A is a residue of a protein or polypeptide:
- X is a bivalent rganic radical or may b absent;
- and
- R is a —CO—R, ac talized f rmyl, amino or protected amino group, where R is hydrogen or an aliphatic, cycloaliphatic, aromatic or aliphatic hydrocarbon group, which group may be substituted with the same or a different protein or polypeptide, a reporter group or a cytotoxic agent.
A compound having the formula
- R2′—X′—B′, (III′)
- in which B′ is a residue of DTPA, ferri xamine B or desferrioxamine B, cuprioxamine B, polyglutamic acid and derivatives thereof or [Nε(DPTA-alanyl)-Lys]n with n being an integer >1;
- X′ is a bivalent organic group or may be absent;
- and
- R2′ is a —CO—R, —O—NH2, acetalized formyl, amino or protected amino group, where R is hydrogen or an aliphatic, cycloaliphatic, aromatic or araliphatic hydrocarbon group, which group may be substituted with the same or a different protein or polypeptide, a reporter group or a cytotoxic agent.
Dependencies are inferred from the claim text.